PepTalk 2017
PepTalk 2017

Pipeline Three Icon Pipeline Three Header

Cambridge Healthtech Institute’s Ninth Annual
Optimizing Biologics Formulation Development
Formulation Strategies in an Era of Accelerated Timelines, New Product Formats and Novel Delivery Systems
January 9-10, 2017 | Hilton San Diego Bayfront | San Diego, CA

Each year, the PepTalk Optimizing Biologics Formulation Development meeting brings together an international audience of analytical and formulation scientists from leading industry companies to hear solutions to the most significant challenges in their field. For 2017, the conference focuses on the science and strategies of formulation development in an era of compressed timelines, novel molecular and product formats and products based on novel device and packaging systems.

This important annual congress kicks off the weeklong PepTalk Formulation & Stability pipeline, which also includes separate meetings on Lyophilization and Emerging Drying Technologies and Protein Aggregation and Emerging Analytical Tools. By attending, you may also participate in the full set of seven PepTalk pipelines, including full weeklong sets of meetings on analytics and impurities, process technologies, protein engineering, antibody therapeutics and more.

We invite presentation proposals on the following preliminary topics:

  • Current and Future Trends for End-to-End Formulation and Product Design
  • Molecular Assessment
    • Strategies and methods for developability evaluation
    • Deviceability assessment – bridging formulation and device considerations
  • Product and Dosage Form Design
    • Formulation considerations of the target product profile
    • Formulation and pharmaceutical development impacts of novel modalities
    • Formulation/device co-development and system integration
    • Buffer and excipient selection; constraints of common excipients
    • Formulation design space development
  • Revisiting Platform Formulations
  • Formulation IP in an Era of Biosimilars and Novel Biotherapeutics
  • Dosage Form Changes from FIH to Commercialization
  • Emerging Analytical and Formulation Technologies

Please click here to submit a speaking proposal for review.

Deadline for submission: May 27, 2016

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions about the meeting, please contact:
Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute
Phone: 207-869-9199
Email: ksimmons@healthtech.com

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com